Cannabis battles the symptoms of many conditions but in different ways depending on what exactly the symptoms are, whether it is chronic pain, insomnia or more complex neurological conditions such as epilepsy or even schizophrenia.
Scientists are working hard to discover what exactly it is that cannabis based medicine can or cannot do to assist in neutralizing the symptoms of many disorders and possibly reduce the amount of other pharmaceutical drugs that would otherwise be prescribed to you. They must discover the certain cannabinoids that can help a condition and what combinations of them to use in order to properly dose patients.
Now that medical marijuana is legal in Florida it is important to speak to your doctor to find out what cannabis based medicine can do for your conditions. If you struggle with schizophrenia, then there is promising research being done that has a real potential in helping you battle your schizophrenic symptoms. Have you asked your doctor what cannabis can do for your conditions yet?
Schizophrenia affects about 1.1 percent of the American population – or approximately 3.5 million adults.
The symptoms of schizophrenia are wide-ranging and varied. They include so-called positive symptoms – that is, symptoms that do not appear in healthy individuals – negative symptoms, called negative because they are a disruption to normal behavior, and finally, cognitive symptoms.
The latter category includes difficulty paying attention or concentrating, trouble making decisions, as well as problems with comprehending and using new information.
While currently available medication effectively treats positive symptoms – such as hallucinations and delusions – it is less effective in treating cognitive symptoms and negative symptoms, such as reduced speaking, reduced social interaction, and blunted feelings.
This is why new research looks at the potential of a cannabis compound called cannabidiol (CBD) for treating the more challenging symptoms of schizophrenia.
The new study – published in the journal Nature – was carried out by a team of researchers from the Illawarra Health and Medical Research Institute (IHMRI) in New South Wales, Australia.
CBD can affect learning, memory, and attention, which suggests that the compound could help manage cognitive symptoms more effectively and with fewer side effects than widely available medication.
The researchers – led by Dr. Katrina Green from the University of Wollongong, Australia – first discovered the therapeutic value of CBD when they previously conducted a review of 27 studies.
“From this review, we found that CBD will not improve learning and memory in healthy brains, but may improve aspects of learning and memory in illnesses associated with cognitive impairment, including Alzheimer’s disease, as well as neurological and neuro-inflammatory disorders,” explains Dr. Green.
“Evidence suggests that CBD is neuroprotective and can reduce cognitive impairment associated with use of delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis,” Dr. Green adds.
Based on this evidence, Ph.D. candidate Ashleigh Osborne, together with Dr. Green – who is her supervisor – set out to examine if CBD can reduce cognitive impairment in rodents.
The team – made up of Osborne, Dr. Green, senior professor Xu-Feng Huang, and Ph.D. candidate Ilijana Babic – used a prenatal infection model to investigate the effect of chronic CBD treatment on cognition and social interaction.
First, they infected the pregnant rats in the 15th day of gestation with polyinosinic-polycytidilic acid – a compound commonly used to generate psychiatric disorders such as schizophrenia and autism in rats.
Then, they injected the male rats offspring with 10 milligrams per kilogram of CBD for 3 weeks.